Organization | Centro medicina deportiva Miranda Ebro

Centro medicina deportiva Miranda Ebro Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2018

NCT03760653

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Centro medicina deportiva Miranda Ebro

Active Ingredients

Drugs in Other Trials (4)

bifidobacterium bifidum (1 trial)

Lactobacillus acidophilus (1 trial)

lactobacillus casei (1 trial)

lactobacillus rhamnosus (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 1
# of Trial APIs: 4